MultiStem administration provides Read more…
Amorcyte’s, a NeoStem company (NYSE Amex: NBS) patent award Read more…
New Patent for Diagnosis and Treatment of Ovarian Cancer and Multiple Myeloma Read more…
CYTX received US Patent No. 7,771,716 (“716” patent) for Celution® System based methods Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.